Navigation Links
Stopping Screens for PDS-1000 He and Hepta Systems, 500 from Bio-Rad

ProductsStopping Screens for PDS-1000 He and Hepta Systems, 500 from Bio-Rad
Company Bio-Rad
Item Stopping Screens for PDS-1000 He and Hepta Systems, 500
Price 
Description These stopping screens are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 screens.
Info Bio-RadBio-Rad
Bio-Rad Laboratories, Inc.
Life Science Research Group
2000 Alfred Nobel Drive
Hercules, CA 94547
USA
Customer Service: 800-424 6723
Fax Number: 800-879 2289
Web Site: http://discover.bio-rad.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. PDS-1000 He System from Bio-Rad
2. PDS-1000 He Hepta System from Bio-Rad
3. Hepta Adaptor for PDS-1000 He System from Bio-Rad
4. Macrocarriers, for PDS-1000 He and Hepta systems, 500 from Bio-Rad
5. 500 Optimization Kit, PDS-1000 He and Hepta systems from Bio-Rad
6. KODAK Molecular Imaging Software Regulator Edition from Molecular Imaging Systems, Carestream Health, Inc. (formerly Kodak Molecular Imaging Systems)
7. KODAK Image Station 4000MM Digital Imaging System from Molecular Imaging Systems, Carestream Health, Inc. (formerly Kodak Molecular Imaging Systems)
8. Image Station X-Ray Imaging Module from Molecular Imaging Systems, Carestream Health, Inc. (formerly Kodak Molecular Imaging Systems)
9. Multi-OSMETTE from Precision Systems, Inc.
10. Micro-OSMETTE from Precision Systems, Inc.
11. WR CRYETTE from Precision Systems, Inc.
Breaking Biology Technology:New technology could boost disease detection tests' speed and sensitivity 2Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2